Scott Bunce

Scott Bunce is an Associate Professor at the Penn State University College of Medicine within the Department of Psychiatry and Behavioral Health, Division of Adult Outpatient Services, and affiliated with the Penn State Neuroscience Institute. His work focuses on Opioid Use Disorder (OUD), Prescription Opioid Misuse, and Residential Treatment efficacy.

He employs Ecological Momentary Assessment (EMA) and GLP-1 Receptor Agonists to study craving, relapse, and affect dynamics in OUD treatment. Key grants include funding from the National Institute on Drug Abuse (NIDA) for projects like "Use of a GLP-1 Agonist to Treat OUD in Rats and Man" (2024-2027).

• Education: PhD and MA from University of Michigan Medical Center (Ann Arbor, 1991-1993)

His research intersects with UN Sustainable Development Goals related to health and well-being. Collaborations span neuroscience and addiction treatment, with a focus on optical brain imaging and prescription opioid dependence. Publications highlight his h-index of 28 and 69 total research outputs.

Current projects include clinical trials on GLP-1 receptor agonists for OUD treatment, with recent articles in Substance Use and Misuse and Addiction Science and Clinical Practice. His work bridges functional near-infrared spectroscopy (fNIRS) and cognitive load analysis in addiction recovery.